ASX - By Stock
|
IMM |
Re:
Ann: Change of Director's Interest Notice - R Howard
|
|
Mr Share
|
13 |
5.3K |
2 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
13
|
5.3K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Update on MBC trial design following successful FDA meeting
|
|
Mr Share
|
22 |
12K |
12 |
25/12/22 |
25/12/22 |
ASX - By Stock
|
22
|
12K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Mr Share
|
2.9K |
1.2M |
15 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
2.9K
|
1.2M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
Mr Share
|
43 |
22K |
5 |
12/03/22 |
12/03/22 |
ASX - By Stock
|
43
|
22K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Mr Share
|
382 |
198K |
20 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
382
|
198K
|
20
|
|
ASX - By Stock
|
IMM |
Re:
a current prediction
|
|
Mr Share
|
128 |
774K |
12 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
128
|
774K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Mr Share
|
108 |
45K |
11 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
108
|
45K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Mr Share
|
108 |
45K |
8 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
108
|
45K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Mr Share
|
743 |
348K |
10 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
743
|
348K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Mr Share
|
743 |
348K |
3 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
743
|
348K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Mr Share
|
743 |
348K |
9 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
743
|
348K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep achieves Fast Track designation for Efti from US FDA
|
|
Mr Share
|
68 |
45K |
11 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
68
|
45K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Just like morning ‘ups’
|
|
Mr Share
|
29 |
10K |
13 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
29
|
10K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report & Appendix 4C
|
|
Mr Share
|
38 |
15K |
23 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
38
|
15K
|
23
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Presentation
|
|
Mr Share
|
59 |
14K |
18 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
59
|
14K
|
18
|
|
ASX - By Stock
|
IMM |
Van Leeuwenhoeck Institute Research
|
|
Mr Share
|
4 |
3.3K |
13 |
28/04/18 |
28/04/18 |
ASX - By Stock
|
4
|
3.3K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
overnight news from USA
|
|
Mr Share
|
569 |
228K |
5 |
14/04/18 |
14/04/18 |
ASX - By Stock
|
569
|
228K
|
5
|
|
ASX - By Stock
|
IMM |
New Edison Research
|
|
Mr Share
|
6 |
3.3K |
3 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
6
|
3.3K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
Mr Share
|
629 |
257K |
3 |
27/02/18 |
27/02/18 |
ASX - By Stock
|
629
|
257K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Half Yearly Report and Accounts
|
|
Mr Share
|
8 |
3.2K |
11 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
8
|
3.2K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
FEB??
|
|
Mr Share
|
8 |
3.7K |
10 |
05/02/18 |
05/02/18 |
ASX - By Stock
|
8
|
3.7K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
Mr Share
|
629 |
257K |
5 |
17/12/17 |
17/12/17 |
ASX - By Stock
|
629
|
257K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
Mr Share
|
629 |
257K |
0 |
17/12/17 |
17/12/17 |
ASX - By Stock
|
629
|
257K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
Mr Share
|
629 |
257K |
4 |
17/12/17 |
17/12/17 |
ASX - By Stock
|
629
|
257K
|
4
|
|
ASX - By Stock
|
IMM |
* article
|
|
Mr Share
|
5 |
3.3K |
10 |
26/11/17 |
26/11/17 |
ASX - By Stock
|
5
|
3.3K
|
10
|
|
ASX - By Stock
|
IMM |
Share price
|
|
Mr Share
|
1 |
4.9K |
15 |
13/11/17 |
13/11/17 |
ASX - By Stock
|
1
|
4.9K
|
15
|
|
ASX - By Stock
|
IMM |
Van Leeuwenhoeck Institute Research
|
|
Mr Share
|
6 |
3.3K |
12 |
26/08/17 |
26/08/17 |
ASX - By Stock
|
6
|
3.3K
|
12
|
|
ASX - By Stock
|
IMM |
New Edison Research
|
|
Mr Share
|
4 |
2.2K |
1 |
08/07/17 |
08/07/17 |
ASX - By Stock
|
4
|
2.2K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
The Pharma Letter article
|
|
Mr Share
|
9 |
9.7K |
2 |
15/06/17 |
15/06/17 |
ASX - By Stock
|
9
|
9.7K
|
2
|
|
ASX - By Stock
|
IMM |
The Pharma Letter article
|
|
Mr Share
|
9 |
9.7K |
3 |
15/06/17 |
15/06/17 |
ASX - By Stock
|
9
|
9.7K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Long term holder losing patient!
|
|
Mr Share
|
24 |
10K |
5 |
10/06/17 |
10/06/17 |
ASX - By Stock
|
24
|
10K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
EGM Resolutions
|
|
Mr Share
|
8 |
4.6K |
1 |
06/07/15 |
06/07/15 |
ASX - By Stock
|
8
|
4.6K
|
1
|
|
ASX - By Stock
|
IMM |
news article on prr
|
|
Mr Share
|
13 |
2.0K |
20 |
11/11/13 |
11/11/13 |
ASX - By Stock
|
13
|
2.0K
|
20
|
|
ASX - By Stock
|
IMM |
better days are ahead
|
|
Mr Share
|
0 |
356 |
5 |
13/09/12 |
13/09/12 |
ASX - By Stock
|
0
|
356
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 4E & 2012 Full Year Statutory Accou
|
|
Mr Share
|
4 |
549 |
3 |
01/09/12 |
01/09/12 |
ASX - By Stock
|
4
|
549
|
3
|
|
ASX - By Stock
|
IMM |
Re:
recruitment for can003 trial phase
|
|
Mr Share
|
53 |
3.4K |
4 |
25/08/12 |
25/08/12 |
ASX - By Stock
|
53
|
3.4K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
the power of patents
|
|
Mr Share
|
10 |
1.3K |
4 |
12/07/12 |
12/07/12 |
ASX - By Stock
|
10
|
1.3K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
the power of patents
|
|
Mr Share
|
10 |
1.3K |
3 |
12/07/12 |
12/07/12 |
ASX - By Stock
|
10
|
1.3K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
a good time to buy?
|
|
Mr Share
|
50 |
4.4K |
0 |
26/05/12 |
26/05/12 |
ASX - By Stock
|
50
|
4.4K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
a good time to buy?
|
|
Mr Share
|
50 |
4.4K |
2 |
26/05/12 |
26/05/12 |
ASX - By Stock
|
50
|
4.4K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
shorting
|
|
Mr Share
|
58 |
3.8K |
11 |
11/05/12 |
11/05/12 |
ASX - By Stock
|
58
|
3.8K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
tick up reversal day
|
|
Mr Share
|
89 |
6.6K |
15 |
30/04/12 |
30/04/12 |
ASX - By Stock
|
89
|
6.6K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
wow
|
|
Mr Share
|
62 |
5.1K |
0 |
24/04/12 |
24/04/12 |
ASX - By Stock
|
62
|
5.1K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
wow
|
|
Mr Share
|
62 |
5.1K |
2 |
24/04/12 |
24/04/12 |
ASX - By Stock
|
62
|
5.1K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
wow
|
|
Mr Share
|
62 |
5.1K |
29 |
24/04/12 |
24/04/12 |
ASX - By Stock
|
62
|
5.1K
|
29
|
|
ASX - By Stock
|
IMM |
Re:
a warm welcome from the nasdaq family
|
|
Mr Share
|
12 |
2.0K |
28 |
18/04/12 |
18/04/12 |
ASX - By Stock
|
12
|
2.0K
|
28
|
|
ASX - By Stock
|
IMM |
Re:
buyer build up
|
|
Mr Share
|
31 |
2.4K |
31 |
12/04/12 |
12/04/12 |
ASX - By Stock
|
31
|
2.4K
|
31
|
|
ASX - By Stock
|
IMM |
Re:
how may days before listing after form f-6
|
|
Mr Share
|
29 |
2.2K |
13 |
07/04/12 |
07/04/12 |
ASX - By Stock
|
29
|
2.2K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
how may days before listing after form f-6
|
|
Mr Share
|
29 |
2.2K |
1 |
07/04/12 |
07/04/12 |
ASX - By Stock
|
29
|
2.2K
|
1
|
|
ASX - By Stock
|
IMM |
dubai sales
|
|
Mr Share
|
0 |
402 |
16 |
02/04/12 |
02/04/12 |
ASX - By Stock
|
0
|
402
|
16
|
|